Biovail’s Tramadol ER Still Needs Clinical Trial, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Biovail will undertake a new clinical trial for its extended release tramadol following FDA’s preliminary comments on the company’s response to an “approvable” letter. Biovail expects to submit data from the new clinical trial in late 2005 or early 2006.